期刊文献+

微型化介质研磨法制备槲皮素纳米混悬剂 被引量:23

Preparation of nanosuspension of quercetin with a miniaturized milling method
原文传递
导出
摘要 采用Box-Behnken设计-效应面法优化一种微型化介质研磨法制备槲皮素纳米混悬剂(QT-NS)的工艺参数并评价所制得的QT-NS的体外累积释放度。结果显示,以最优工艺参数:氧化锆珠子4.5 m L、研磨速度690 r·min-1、研磨时间1.5 h,制得的QT-NS的粒径为(169±5)nm,多分散度指数为0.204±0.006,稳定系数为0.827±0.014,且理论预测值与实测值偏差较小,模型具有良好的预测性;在120 min体外累积释放度实验中,QT-NS明显高于原料药和物理混合物。使用该种微型化介质研磨法能成功制备QT-NS,且该方法中原料药消耗少,工艺简单、操作方便,可为纳米制剂的制备提供新的参考。 The nanosuspension of quercetin (QT-NS) was prepared by a miniaturized milling method, and the process was opti- mized by Box-Behnken response surface method. Then the accumulative release rate of QT-NS in vitro was determined. The resuhs showed that the optimal process parameters were as follows : ZrO24. 5 mL, milling speed 690 r · min - 1 and milling time 1.5 h ; the par- ticle size of QT-NS was ( 169 ± 5 ) nm, polydispersity index of 0. 204 ±0. 006 and stability index of 0. 827 ± 0. 014, respectively. There was a little deviation between the theoretically predicted value and the measured value, indicating that this model had a good pre- diction effect. The accumulative release rate in vitro of QT-NS in 120 min was significantly higher than that of the raw drug and physical mixture. This simple low-cost miniaturization approach could prepare QT-NS successfully, and could provide reference for the formula- tion of the nanosuspension.
出处 《中国中药杂志》 CAS CSCD 北大核心 2017年第15期2984-2988,共5页 China Journal of Chinese Materia Medica
基金 国家自然科学基金项目(81573697) 后勤科研重点项目(BKJ16J011)
关键词 槲皮素 纳米混悬剂 微型化介质研磨法 体外释放 quercetin nanosuspension miniaturized milling method in vitro release
  • 相关文献

参考文献3

二级参考文献18

  • 1朱建芬,吴祥根.纳米混悬剂的制备方法及在药剂学中应用的研究进展[J].中国医药工业杂志,2006,37(3):196-200. 被引量:38
  • 2赵李宏,吴建梅,武凤兰.α-细辛脑近10年研究概述[J].中国中药杂志,2007,32(7):562-565. 被引量:56
  • 3杨正鸿,吴闯.α-细辛脑在人体的生物利用度研究[J].中国医院药学杂志,1997,17(4):165-167. 被引量:29
  • 4Wu J, Chen D, Zhang R. Study on the bioavailability of baica- lin-phospholipid complex by using HPLC [ J ]. Biomed Chroma- togr, 1999, 13(7) : 493.
  • 5Rainer H M, Katrin P. Nanosuspensions for the formulation of poorly soluble drugs: I. preparation by a size-reduction technique [J]. Int J Pharm, 1998, 160(2): 229.
  • 6vanEerdenbmgh B, Vermant J, Martens J A, et al. A screening study of surface stabilization during the production of drug nano- crystals[J]. J Pharm Sci, 2009, 98(6) : 2091.
  • 7Owen H, Graham S, Werling J O, et al. Anion effects on elec- trostatic eharging of sterieally stabilized, water insoluble drug par- ticles[ J]. Int J Pharm, 2009, 368 (1/2) : 154.
  • 8Duchene D, Ponchel G. Bioadhesion of solid oral dosageform, why and how[J]. Eur J Phann Biopharm, 1997, 44(1) : 15.
  • 9Jennifer B D, Hans L. Oral drug absorption [ M ]. New York : Marcel Dekker, 2001 : 212.
  • 10Mosharraf S M, Nystrom C. The effect of particle size and shape on the surface special dissolution rate of micronized practically in- soluble drugs[J]. Int J Pharm, 1995, 122(12) : 35.

共引文献37

同被引文献233

引证文献23

二级引证文献179

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部